readthroughSign in
CompanyWHWKNasdaqMorristown, NJ

Whitehawk Therapeutics, Inc.

Whitehawk Therapeutics develops antibody-drug conjugates for oncology, including HWK-007, HWK-016, and HWK-206 in clinical development.

Stories only
SEC EDGARClinicalTrials.govwhitehawktx.com
8-KSep 10Latest SEC filing, period to Sep 9
Sep 10Latest story

September 2026

August 2026